Related Experiment Video
Updated: Feb 15, 2026

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue
Published on: May 1, 2019
Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1
Zhengyuan Zhang1, Mingyang Shen2, Guangrong Zhou1
1Department of Gastrointestinal Surgery, Huai'an First People's Hospital, Affiliated to Nanjing Medical University, Huai'an City, Jiangsu Province, PR China.
Abstract:
The cell division cycle associated 5(CDCA5) was reported to be associated with progression of several human cancers, however, its clinical significance and biological role still remain unknown in gastric cancer(GC). By analyzing The Cancer Genome Atlas(TCGA), we found CDCA5 was significantly upregulated in GC tissues compared to adjacent normal tissues. Tissue microarray(TMA) indicated upregulation of CDCA5 was significantly correlated with more advanced clinicopathological features, and acts as an independent risk factor for worse overall survival(OS) in GC patients. Moreover, silence of CDCA5 suppresses proliferation of GC cells by inducing G1-phase arrest via downregulating Cyclin E1(CCNE1). Our results demonstrate upregulation of CDCA5 promotes GC malignant progression, which may offer a potential prognostic and therapeutic strategy.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
E1 Reaction: Kinetics and Mechanism
E1 Reaction: Stereochemistry and Regiochemistry
The Eukaryotic Promoter Region
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Gastric Emptying

